• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2300639 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs Supplementary Application 2023-11-08 Sanofi Winthrop Industrie view
JYHZ2200220 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs License Renew 2022-08-17 Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
CYHS2403194 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs(4) Generic Drug 2024-09-25 Sanofi (Hangzhou) Pharmaceutical Co Ltd view
JYHZ2200222 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs License Renew 2022-08-17 Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
CYHB2301441 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs(4) Supplementary Application 2023-06-29 Jiangxi Shimei Pharmaceutical Co Ltd;Hebei Xinshi Pharmaceutical Co Ltd view
JYHB2300637 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs Supplementary Application 2023-11-08 Sanofi Winthrop Industrie view
JYHZ2200221 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs License Renew 2022-08-17 Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
CYHB2200294 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs(4) Supplementary Application 2022-02-10 Hunan Jiudian Pharmaceutical Co Ltd;Shandong Xinhua Pharmaceutical Company Limited view
JYHB2400385 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs Supplementary Application 2024-07-24 Sanofi Winthrop Industrie view
CYHS2300924 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs(4) Generic Drug 2023-03-29 Zhejiang Jingxin Pharmaceutical Co Ltd view
JYHB2300638 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs Supplementary Application 2023-11-08 Sanofi Winthrop Industrie view
JYHZ2200223 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs License Renew 2022-08-17 Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
JYHB2400384 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs Supplementary Application 2024-07-24 Sanofi Winthrop Industrie view
JYHB2101411 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs Supplementary Application 2021-09-15 Sanofi-Aventis Groupe;Sanofi Winthrop Industrie view
CYHS2501678 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs(4) Generic Drug 2025-05-09 Hunan Weite Pharmaceutical Co Ltd view
JYHB2300640 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs Supplementary Application 2023-11-08 Sanofi Winthrop Industrie view
CYHS2102080 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs(4) Generic Drug 2021-11-25 Jiangsu Changjiang Pharmaceutical Co Ltd;Jiangsu Zhongzhi Pharmaceutical Co Ltd view
CYHS2402184 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs(4) Generic Drug 2024-07-16 Ningbo Menovo TianKang Pharmaceutical Co Ltd view
CYHS2501627 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs(4) Generic Drug 2025-05-01 Guangzhou Baiyunshan Tianxin Pharmaceutical Co Ltd view
CYHB2201690 厄贝沙坦氢氯噻嗪片 hydrochlorothiazide;irbesartan Tablet Chemical Drugs(4) Supplementary Application 2022-09-20 Zhuhai Rundu Pharmaceutical Co Ltd view